Fred Knoll
@Knoll Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$215.8MTotal holdings36
Assets growth rate45.42%Assets growth rate (2-Q avg)18.88%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Knoll Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.
Assets under management
The assets under management (AUM) of Knoll Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 215.8M in assets, with a quarterly growth rate of 45.42% and a 2-quarter average growth rate of 18.88%. The portfolio is managed by Fred Knoll, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
APLTApplied Therapeutics Inc
| 21.96% | $47.385M 5.575M shares@ $8.5 avg price | |
BHVNBiohaven Pharmactl Hldg Co L
| 16.46% | $35.5M 710,422 shares@ $49.97 avg price | |
ALDXAldeyra Therapeutics Inc
| 13.68% | $29.513M 5.476M shares@ $5.39 avg price | |
AGIAlamos Gold Inc
| 4.09% | $8.818M 41,000 shares@ $215.07 avg price | Decreased -48.75% |
AVDLAvadel Pharmaceuticals Plc
| 3.65% | $7.869M 600,000 shares@ $13.12 avg price | |
GLDSpdr Gold Trust
| 3.61% | $7.778M 32,000 shares@ $243.06 avg price | |
ENTXEntera Bio Ltd
| 3.42% | $7.376M 3.882M shares@ $1.9 avg price | |
HOOKHookipa Pharma
| 3.34% | $7.191M 551,738 shares@ $13.04 avg price | Decreased -90% |
ALTAltimmune Inc
| 3.2% | $6.886M 1.122M shares@ $6.14 avg price | |
VRNAVerona Pharma
| 2.67% | $5.754M 200,000 shares@ $28.77 avg price |